Related references
Note: Only part of the references are listed.Synthesis and In Vitro Evaluation of 8-Pyridinyl-Substituted Benzo[e]imidazo[2,1-c][1,2,4]triazines as Phosphodiesterase 2A Inhibitors
Rien Ritawidya et al.
MOLECULES (2019)
Structure-activity relationships of thiazole and benzothiazole derivatives as selective cannabinoid CB2 agonists with in vivo anti-inflammatory properties
Aya E. Ghonim et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Benzofuran and pyrrole derivatives as cannabinoid receptor modulators with in vivo efficacy against ulcerative colitis
Noura E. Wadea et al.
FUTURE MEDICINAL CHEMISTRY (2019)
Radioligands for positron emission tomography imaging of cannabinoid type 2 receptor
Francesco Spinelli et al.
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS (2018)
The Endogenous Cannabinoid System: A Budding Source of Targets for Treating Inflammatory and Neuropathic Pain
Giulia Donvito et al.
NEUROPSYCHOPHARMACOLOGY (2018)
Perspectives of Cannabinoid Type 2 Receptor (CB2R) Ligands in Neurodegenerative Disorders: Structure-Affinity Relationship (SAfiR) and Structure-Activity Relationship (SAR) Studies
Francesco Spinelli et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Targeting the endocannabinoid system: future therapeutic strategies
Oier Aizpurua-Olaizola et al.
DRUG DISCOVERY TODAY (2017)
Medicinal Chemistry, Pharmacology, and Potential Therapeutic Benefits of Cannabinoid CB2 Receptor Agonists
Mojgan Aghazadeh Tabrizi et al.
CHEMICAL REVIEWS (2016)
Discovery of novel Tetrahydrobenzo[b]thiophene and pyrrole based scaffolds as potent and selective CB2 receptor ligands: The structural elements controlling binding affinity, selectivity and functionality
Noha A. Osman et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Decreased in vivo availability of the cannabinoid type 2 receptor in Alzheimer's disease
Rawaha Ahmad et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2016)
Development of a High-Affinity PET Radioligand for Imaging Cannabinoid Subtype 2 Receptor
Rares-Petru Moldovan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Synthesis and Biological Evaluation of Thiophene-Based Cannabinoid Receptor Type 2 Radiotracers for PET Imaging
Ahmed Haider et al.
FRONTIERS IN NEUROSCIENCE (2016)
CB2 Cannabinoid Receptor As Potential Target against Alzheimer's Disease
Ester Aso et al.
FRONTIERS IN NEUROSCIENCE (2016)
Synthesis, radiolabeling and evaluation of novel 4-oxo-quinoline derivatives as PET tracers for imaging cannabinoid type 2 receptor
Roger Slavik et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2015)
Differential upregulation of the cannabinoid CB2 receptor in neurotoxic and inflammation-driven rat models of Parkinson's disease
Ruth M. Concannon et al.
EXPERIMENTAL NEUROLOGY (2015)
Discovery of a High Affinity and Selective Pyridine Analog as a Potential Positron Emission Tomography Imaging Agent for Cannabinoid Type 2 Receptor
Roger Slavik et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Cannabinoid CB2 Receptors in a Mouse Model of Aβ Amyloidosis: Immunohistochemical Analysis and Suitability as a PET Biomarker of Neuroinflammation
Alena V. Savonenko et al.
PLOS ONE (2015)
Benzimidazole CB2 agonists: Design, synthesis and SAR
Kausik K. Nanda et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2014)
Parsing the players: 2-arachidonoylglycerol synthesis and degradation in the CNS
N. Murataeva et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Development and Evaluation of Novel PET Tracers for Imaging Cannabinoid Receptor Type 2 in Brain
Roger Slavik et al.
CHIMIA (2014)
Adverse Health Effects of Marijuana Use
Nora D. Volkow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Cannabinoids as therapeutic agents in cancer: current status and future implications
Bandana Chakravarti et al.
ONCOTARGET (2014)
Therapeutic Utility of Cannabinoid Receptor Type 2 (CB2) Selective Agonists
Sangdon Han et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Whole-Body Biodistribution and Radiation Dosimetry of the Cannabinoid Type 2 Receptor Ligand [11C]-NE40 in Healthy Subjects
Rawaha Ahmad et al.
MOLECULAR IMAGING AND BIOLOGY (2013)
Latest advances in novel cannabinoid CB2 ligands for drug abuse and their therapeutic potential
Peng Yang et al.
FUTURE MEDICINAL CHEMISTRY (2012)
Preclinical evaluation of [11C]NE40, a type 2 cannabinoid receptor PET tracer
Nele Evens et al.
NUCLEAR MEDICINE AND BIOLOGY (2012)
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities
Roger G. Pertwee
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2012)
Synthesis, in vitro and in vivo evaluation of fluorine-18 labelled FE-GW405833 as a PET tracer for type 2 cannabinoid receptor imaging
Nele Evens et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Novel indole and azaindole (pyrrolopyridine) cannabinoid (CB) receptor agonists: Design, synthesis, structure-activity relationships, physicochemical properties and biological activity
Antoni R. Blaazer et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
A PET Brain Reporter Gene System Based on Type 2 Cannabinoid Receptors
Caroline Vandeputte et al.
JOURNAL OF NUCLEAR MEDICINE (2011)
Synthesis and biodistribution of [11C] A-836339, a new potential radioligand for PET imaging of cannabinoid type 2 receptors (CB2)
Andrew G. Horti et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Endocannabinoid Binding to the Cannabinoid Receptors: What Is Known and What Remains Unknown
Patricia H. Reggio
CURRENT MEDICINAL CHEMISTRY (2010)
Non-Invasive Imaging of the Type 2 Cannabinoid Receptor, Focus on Positron Emission Tomography
Nele Evens et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2010)
Characterization of a Cannabinoid CB2 Receptor-Selective Agonist, A-836339 [2,2,3,3-Tetramethyl-cyclopropanecarboxylic Acid [3-(2-Methoxy-ethyl)-4,5-dimethyl-3H-thiazol-(2Z)-ylidene]-amide], Using in Vitro Pharmacological Assays, in Vivo Pain Models, and Pharmacological Magnetic Resonance Imaging
Betty B. Yao et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
Endocannabinoids and immune regulation
Rupal Pandey et al.
PHARMACOLOGICAL RESEARCH (2009)
Cannabinoid CB2 receptors in human brain inflammation
C. Benito et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
The endocannabinoid system and energy metabolism
L. Bellocchio et al.
JOURNAL OF NEUROENDOCRINOLOGY (2008)
Postsynaptic Localization of CB2 Cannabinoid Receptors in the Rat Hippocampus
Alicia Brusco et al.
SYNAPSE (2008)
Identification and functional characterization of brainstem cannabinoid CB2 receptors
MD Van Sickle et al.
SCIENCE (2005)
Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy
KJ Valenzano et al.
NEUROPHARMACOLOGY (2005)
A glial endogenous cannabinoid system is upregulated in the brains of macaques with simian immunodeficiency virus-induced encephalitis
C Benito et al.
JOURNAL OF NEUROSCIENCE (2005)
Rational design and synthesis of an orally active indolopyridone as a novel conformationally constrained cannabinoid ligand possessing antiinflammatory properties
ST Wrobleski et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
The molecular logic of endocannabinoid signalling
D Piomelli
NATURE REVIEWS NEUROSCIENCE (2003)
C-3 amido-indole cannabinoid receptor modulators
J Hynes et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2002)
Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease
RJ McKallip et al.
BLOOD (2002)
Share Paper
